Mark Gruppetta
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Glioma Diagnosis and Treatment
- Diabetes and associated disorders
Papers in
-
- Pituitary Gland Disorders and Treatments 9
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Surgery 8
- Adrenal and Paraganglionic Tumors 4
- Co-authors
- Josanne Vassallo (10 shared papers)Cecilia Mercieca (2 shared papers)Stephen Fava (4 shared papers)Neville Calleja (1 shared paper)Andrew Cassar (1 shared paper)Angela Xuereb‐Anastasi (1 shared paper)James Clark (1 shared paper)Matthew Mercieca Balbi (1 shared paper)
- Journals
- Clinical Medicine (2 papers)Pituitary (2 papers)HORMONES (1 paper)Endocrine Pathology (1 paper)Clinical Cardiology (1 paper)
- Partner nations
- MaltaUnited Kingdom
In The Last Decade
Mark Gruppetta
30 papers receiving 463 citations
Peers
Comparison fields: 5 of 68
- Endocrinology, Diabetes and Metabolism 297
- Genetics 44
- Family Practice 6
- Surgery 95
- Biological Psychiatry 4
Countries citing papers authored by Mark Gruppetta
This map shows the geographic impact of Mark Gruppetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gruppetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gruppetta more than expected).
Fields of papers citing papers by Mark Gruppetta
This network shows the impact of papers produced by Mark Gruppetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gruppetta. The network helps show where Mark Gruppetta may publish in the future.
Co-authors
The 13 scholars most cited alongside Mark Gruppetta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 173 | |
| 2 | 2018 | 85 | |
| 3 | 2017 | 28 | |
| 4 | 2016 | 22 | |
| 5 | 2012 | 21 | |
| 6 | 2020 | 20 | |
| 7 | 2010 | 14 | |
| 8 | 2010 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2012 | 10 | |
| 11 | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | 2020 | 8 |
| 12 | 2016 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2020 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2021 | 4 |
About Mark Gruppetta
Mark Gruppetta is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Nephrology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 473 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (9 papers), Adrenal and Paraganglionic Tumors (4 papers), Diabetes and associated disorders (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Parathyroid Disorders and Treatments (2 papers), Glioma Diagnosis and Treatment (2 papers), Electrolyte and hormonal disorders (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (297 citations), Genetics (44 citations), Family Practice (6 citations), Surgery (95 citations) and Biological Psychiatry (4 citations). Mark Gruppetta has collaborated with scholars based in Malta and United Kingdom. Frequent co-authors include Josanne Vassallo, Cecilia Mercieca, Stephen Fava, Neville Calleja, Andrew Cassar, Angela Xuereb‐Anastasi, James Clark, Matthew Mercieca Balbi, Nikolai Paul Pace and Alex E. Felice. Their work appears in journals such as Clinical Medicine, Pituitary, HORMONES, Endocrine Pathology and Clinical Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.